➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Colorcon
Moodys
Boehringer Ingelheim
Baxter

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Collagenase - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for collagenase

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Endo PharmaceuticalsPhase 2
Mansoura UniversityN/A
University Hospital, GhentEarly Phase 1

See all collagenase clinical trials

Recent Litigation for collagenase

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
KYTHERA BIOPHARMACEUTICALS, INC. v. SLAYBACK PHARMA LLC2018-11-09
TerreStar Networks Inc.2010-10-19

See all collagenase litigation

PTAB Litigation
PetitionerDate
2018-07-17
2017-04-04
2015-06-15

See all collagenase litigation

Pharmacology for collagenase
Ingredient-typeCollagenases

Company Disclosures: US Patents for collagenase

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Start Trial Advance Biofactures of Curacao (Curacao, AN) 2039-03-29 RX company
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Start Trial Auxilium US Holdings, LLC (Wilmington, DE) 2026-01-30 RX company
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Start Trial Advance Biofactures Corporation (Lynbrook, NY) 2039-02-26 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for collagenase

These patents were identified by searching patent claims

Supplementary Protection Certificates for collagenase

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB10/030 United Kingdom   Start Trial PRODUCT NAME: AGALSIDASE ALFA; REGISTERED: UK EU/1/01/189/001 20010807
13/054 Ireland   Start Trial PRODUCT NAME: AGALSIDASE BETA; REGISTRATION NO/DATE: EU/1/01/188/001-006 20010803
299011 Germany   Start Trial PRODUCT NAME: KINERET(R) (WIRKSAMER BESTANDTEIL ANAKINRA); REGISTRATION NO/DATE: EU/1/02/203/001-004 20020308
/2010 Austria   Start Trial PRODUCT NAME: AGALSIDASE ALPHA; REGISTRATION NO/DATE: EU/1/01/189/001 20010803
704 Luxembourg   Start Trial 91704, EXPIRES: 20160803
2013 00047 Denmark   Start Trial PRODUCT NAME: MIKROPLASMIN HERUNDER OCRIPLASMIN; REG. NO/DATE: EU/1/13/819/001 20130315
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
AstraZeneca
Baxter
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.